|
Anthem Biosciences, a CRDMO, is set to launch an IPO to raise 3,395 crore, diluting the promoter group's stake. While revenue and profit have increased, the company faces geographical and client concentration risks. Despite a high P/E ratio compared to peers, investors with a high-risk tolerance may find the IPO appealing.
Category:
News and Media
Last week, the Nifty fell below key averages, prompting a cautious short-term outlook due to global weakness and disappointing earnings. Analysts suggest 25,000 is a crucial support level, with a rebound needing to reclaim 25,400. FMCG, power, insurance, and railway stocks are exhibiting relative strength, offering potential opportunities amidst the market uncertainty.
Category:
News and Media
Following SEBI's ban on Jane Street for alleged market manipulation, India's futures and options volumes experienced a significant drop last week. The daily average turnover in index options on the NSE fell by 17.4%, impacting market liquidity and efficiency.
Category:
News and Media
All news |
||||||||||||||||||
|